Improving Diabetes Efforts Across Language and Literacy (IDEALL)

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Agency for Healthcare Research and Quality (AHRQ) The Commonwealth Fund California HealthCare Foundation National Center for Research Resources (NCRR)
Information provided by:	Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier:	NCT00214474

Purpose

The IDEALL Project (Improving Diabetes Efforts Across Language and Literacy) is a 3-arm randomized controlled trial to explore contextual factors at the patient, clinician, and organizational level of two patient self-management support strategies. A communication technology-based intervention (automated telephone diabetes management) and an interpersonally-oriented intervention (group medical visits)will be compared to usual care for their ability to improve diabetes outcomes among vulnerable populations in 4 safety-net health centers in the UCSF Collaborative Research Network.

Condition	Intervention	Phase
Diabetes	Behavioral: 2 types of chronic disease management models	Phase I Phase II

MedlinePlus related topics: Diabetes

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Safety/Efficacy Study
Official Title:	Improving Diabetes Efforts Across Language and Literacy (IDEALL)

Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Primary Outcome Measures:

CHANGES IN HbA1C.
UTILIZATION.
BLOOD PRESSURE.
SELF-CARE.
SELF-EFFICACY.

Secondary Outcome Measures:

Compare the effects of interventions with respect to each other as Usual Care.

Estimated Enrollment:	399
Study Start Date:	November 2002
Estimated Study Completion Date:	November 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

have type 2 diabetes
have a HbA1c equal to or > 8.0%
must speak English, Spanish, or Cantonese.

Exclusion Criteria:

Dementia
Psychosis/Schizophrenia
End Stage Renal Disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00214474

Locations

United States, California
Ucsf Dept of Medicine Box 1364
San Francisco, California, United States, 94143-1364

Sponsors and Collaborators

Agency for Healthcare Research and Quality (AHRQ)

The Commonwealth Fund

California HealthCare Foundation

National Center for Research Resources (NCRR)

Investigators

Study Chair:

MARGARET HANDLEY, Ph.D.

UCSF DEPT. OF MEDICINE

More Information

Study ID Numbers:	1 R21 HS014864-01
Study First Received:	September 19, 2005
Last Updated:	September 19, 2005
ClinicalTrials.gov Identifier:	NCT00214474
Health Authority:	United States: Federal Government

Keywords provided by Agency for Healthcare Research and Quality (AHRQ):

Disease Management
Health Literacy
Telephone Care
Group Medical Visits

Type 2 Diabetes
Access to Care
Technology
Language Barriers

Study placed in the following topic categories:

Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases

Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on January 14, 2009